LOS GATOS, CA / ACCESS Newswire / November 3, 2025 /Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company ...

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device and biologics company with a spine and extremities focus, today announced the U.S. Food and Drug ...

Astura Medical earned FDA 510(k) clearance for the Masada Sacral-Alar-Iliac system, the medtech company said in a Nov. 3 LinkedIn post. The system is designed for sacroiliac joint fixation and fusion ...

Established as the market leader in the minimally invasive approach to sacroiliac (SI) joint fusion, SI-BONE, is now transitioning into a comprehensive sacropelvic solutions company. Over the past 10 ...

New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction SANTA CLARA, Calif., May 29, 2020 (GLOBE ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers of this level 1 study found patients with ...

Rockville, April 17, 2023 (GLOBE NEWSWIRE) -- The global sacroiliac joint fusion market is expected to be worth US$ 620 million in 2022 and US$ 3,900 million by 2032. During the projected period of ...

Please provide your email address to receive an email when new articles are posted on . Zyga Technology recently announced the launch and first commercial use of its updated SImmetry Sacroiliac Joint ...

SI-Bone's iFuse Implant System is one state away from nationwide Medicare coverage. Medicare Administrative Contractor National Government Services has agreed to reimburse the spinal implant used to ...

ST. LOUIS--(BUSINESS WIRE)--CoreLink, LLC, a fast growing designer and manufacturer of spinal implant systems, is pleased to announce the U.S. launch of the Entasis™ Sacroiliac Joint Fusion System.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device and biologics company with a spine and extremities focus, today announced the U.S. Food and Drug ...